Publications by authors named "Petr Brabec"

Claim this Profile
I
Impact of Delaying the Addition of Anti-EGFR in First Line of RAS Wild-Type Metastatic Colorectal Cancer: A Propensity-Weighted Pooled Data Analysis.
Lola-Jade Palmieri, Tomas Buchler, Antoine Meyer, Veronika Veskrnova, Ondrej Fiala, Petr Brabec

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients.
Julia Kovacova, Jaroslav Juracek, Alexandr Poprach, Jindrich Kopecky, Ondrej Fiala, Petr Brabec

Cancer Genomics Proteomics· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.
Zaïda Koeks, Catherine L Bladen, David Salgado, Erik van Zwet, Oksana Pogoryelova, Petr Brabec

J Neuromuscul Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.
Catherine L Bladen, David Salgado, Soledad Monges, Maria E Foncuberta, Kyriaki Kekou, Petr Brabec

Hum Mutat· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry.
Pavel Jansa, Jiri Jarkovsky, Hikmet Al-Hiti, Jana Popelova, David Ambroz, Petr Brabec

BMC Pulm Med· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia.
Catherine L Bladen, Karen Rafferty, Volker Straub, Soledad Monges, Angélica Moresco, Petr Brabec

Hum Mutat· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database.
Alexandr Poprach, Zbyněk Bortlíček, Tomáš Büchler, Bohuslav Melichar, Radek Lakomý, Petr Brabec

Med Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: haemophilia registry data from the Czech Republic.
Peter Salaj, Miroslav Penka, Petr Smejkal, Vera Geierova, Petra Ovesná, Petr Brabec

Thromb Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme.
Ondrej Majek, Jan Danes, Miroslava Skovajsova, Helena Bartonkova, Lucie Buresova, Petr Brabec

BMC Public Health· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma.
John Puetz, Ginger Darling, Petr Brabec, Jan Blatny, Prasad Mathew

Pediatr Blood Cancer· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the DMD/BMD patient population in Czech Republic and Slovakia using an innovative registry approach.
Petr Brabec, Petr Vondrácek, Daniel Klimes, Sarah Baumeister, Hanns Lochmüller

Neuromuscul Disord· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis